日本語 
Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the next stage in Europe. The European Medicines Agency has validated the application. That basically means the file is…
Taletrectinib Moves Toward Europe Approval Review
Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the…
Kiffik Biomedical and HekaBio Alliance Signals a New Era for Real-Time Diagnostics in Asia-Pacific
The Asia-Pacific region is witnessing a paradigm shift in the healthcare technology…
Oxford Nanopore and A.D.A.M. Innovations Partner to Accelerate Genomic Medicine in Japan
Japan's precision medicine ambitions are again being supported by a new partnership…
Microsoft Unveils AI Health Tool Capable of Reading Medical Records, Transforming Digital Healthcare
The competition in healthcare AI is heating up with Microsoft unveiling a…
Exevita and Greenhouse boost practical health management
Exevita Corporation and Green House Co Ltd have started building a joint…
transcosmos partners Tokyo University on pharmacist gap
Transcosmos established a partnership with Tokyo University of Pharmacy and Life Sciences.…
Oxford Nanopore teams with A.D.A.M. for genomic testing
Oxford Nanopore Technologies and A.D.A.M. Innovations have signed a collaboration to bring…
PRISM BioLab and Receptor.AI Build AI Drug Platform
PRISM BioLab and Receptor.AI have signed a collaboration agreement to work together…
English